Rivera, Luciana .

HRN: 25-52-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/03/2025
07/10/2025
IV
500
Q8
Transaminitis Probably Sec To Liver Pathology
Checking Initial Appropriateness 
07/03/2025
CEFTRIAXONE 1G (VIAL)
07/03/2025
07/10/2025
IV
2 Gram
OD
Typhoid Fever With Hepatitis
Checking Initial Appropriateness 
07/06/2025
CEFTAZIDIME 1GM (VIAL)
07/06/2025
07/12/2025
IVT
2g
Q8
Hepatic Encephalopathy
Checking Initial Appropriateness 
07/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/06/2025
07/12/2025
IVT
500mg
Q8
Hepatic Encephalopathy
Checking Initial Appropriateness 
07/10/2025
RIFAXIMIN 200MG (TAB)
07/10/2025
07/17/2025
PO
2 Tabs
TID
Liver Cirrhosis On Decompensation With Biliary Cirrhosis
Checking Initial Appropriateness 
07/17/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/17/2025
07/23/2025
IVTT
4.5g
Every 6hrs
Sepsis Secondary To CAP-HR
Checking Initial Appropriateness 
07/17/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2025
07/23/2025
IVTT
1000mg
Every 48hrs
Sepsis Secondary To CAP-HR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: